Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage

[1] Doorbar J(2012)The biology and life-cycle of human papillomaviruses Vaccine 30 F55-F70

[2] Quint W(2003)Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 518-527

[3] Banks L(1996)High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation J Virol 70 4509-4516

[4] Bravo IG(1989)Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product EMBO J 8 4099-4105

[5] Stoler M(2013)Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes J Clin Virol 57 331-337

[6] Broker TR(2005)Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review Cancer Epidemiol Biomark Prev 14 467-475

[7] Stanley MA(2015)Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis J Oral Pathol Med 44 28-36

[8] Munoz N(2015)Prevalence of human papillomavirus (HPV) and Epstein-Barr virus (EBV) in oral and oropharyngeal squamous cell carcinoma in South-Eastern Poland Infect Agent Cancer 10 37-79

[9] Bosch FX(2000)Comparative study of oral squamous cell carcinoma in Okinawa, southern Japan and Sapporo in Hokkaido, northern Japan; with special reference to human papillomavirus and Epstein-Barr virus infection J Oral Pathol Med 29 70-7832

[10] de Sanjose S(2007)Epstein-Barr virus entry J Virol 81 7825-5121

[1] Doorbar J(2012)The biology and life-cycle of human papillomaviruses Vaccine 30 F55-F70

[2] Quint W(2003)Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 518-527

[3] Banks L(1996)High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation J Virol 70 4509-4516

[4] Bravo IG(1989)Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product EMBO J 8 4099-4105

[5] Stoler M(2013)Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes J Clin Virol 57 331-337

[6] Broker TR(2005)Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review Cancer Epidemiol Biomark Prev 14 467-475

[7] Stanley MA(2015)Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis J Oral Pathol Med 44 28-36

[8] Munoz N(2015)Prevalence of human papillomavirus (HPV) and Epstein-Barr virus (EBV) in oral and oropharyngeal squamous cell carcinoma in South-Eastern Poland Infect Agent Cancer 10 37-79

[9] Bosch FX(2000)Comparative study of oral squamous cell carcinoma in Okinawa, southern Japan and Sapporo in Hokkaido, northern Japan; with special reference to human papillomavirus and Epstein-Barr virus infection J Oral Pathol Med 29 70-7832

[10] de Sanjose S(2007)Epstein-Barr virus entry J Virol 81 7825-5121